English
Home > Products > CAS:3044-42-6

China CAS:3044-42-6 Manufacturer

We have been commitment to offer the aggressive value ,exceptional goods good quality, likewise as fast delivery for CAS:3044-42-6, For anyone who is fascinated in any of our products and solutions, remember to come to feel totally free to get in touch with us for more facts. We hope to cooperate with additional good friends from everywhere in the world.
CAS:3044-42-6, We have been always creating new technology to streamline the production, and offer goods with competitive prices and high quality! Customer satisfaction is our priority! You can let us know your idea to develop unique design for your own model to prevent too much similar parts in the market! We'll offer you our best service to satisfy all your needs! Be sure to contact us right away!

Related Products

Hot Products

  • Methylprednisolone

    Methylprednisolone

    Methylprednisolone has USP, EP, IP, JP and KP specifications. DMF and WC available.

    CAS:83-43-2

  • DHEA Acetate(Prasterone Acetate)

    DHEA Acetate(Prasterone Acetate)

    DHEA Acetate(Prasterone Acetate) is the intermediate of DHEA(prasterone).

    CAS:853-23-6

  • Testosterone Cypionate

    Testosterone Cypionate

    Testosterone Cypionate has USP specification. TP available and DMF under filing.

    CAS:58-20-8

  • Finasteride

    Finasteride

    Finasteride has EP, USP, CP, IP, JP specifications. CEP available, FDA, PMDA and GMP approved.

    CAS:98319-26-7

  • Lasmiditan Succinate

    Lasmiditan Succinate

    Lasmiditan Succinate has In-house specification. DMF approved.

    CAS:439239-92-6

  • 17a-Hydroxyprogesterone

    17a-Hydroxyprogesterone

    17a-Hydroxyprogesterone is an endogenous progesteroid hormone similar to progesterone.

    CAS:68-96-2

  • Related Blog
  • Reviews

  • 2021 API Exhibition Wuhan

    October 2021
    API China is a well-established comprehensive pharmaceuticals and chemicals show in Chinese pharmaceutical industry. With more than 40 years’ experience in China, it has been a well-known celebration for all parties involved in Chinese Pharmaceutical market.

  • Gedian Humanwell successfully passed the EDQM audit

    The API -- cyproterone acetate, successfully passed the EU-GMP audit in April 2024.

  • 2022 API Exhibition Qingdao

    August 2022
    Founded by China National Medical Control Bureau (the predecessor of NPMA) in 1968.
    Gathering 97% of Top 100 Chinese pharmaceutical enterprises.
    99% manufactures meets the requirements of GMP.
    Supported by numerous powerful associations in China: CCFDIE, CPIA, CBPIA, CATCM, CNMA, CNPPA, etc.

  • 2022 CPhI Exhibition Shanghai

    CPhI is the undisputed leader in the pharmaceutical industry. CPhI China offers a key access point to the second largest pharma market in the world. The exhibition features over 3,000 companies and incorporates various API showcases like bioLIVE, iCSE, NEX and FDF, creating a comprehensive platform that connects the entire pharmaceutical industry chain in the Asian-Pacific region.

  • October 24-26, 2023 CPHI Worldwide Pharmaceutical Industry Professional Exhibition in Spain

    Gedian Humanwell is a modern high-tech pharmaceutical company specializing in the R&D, production and sales of fertility regulation drugs and steroidal APIs. Our team will be at API Hall, booth 81B40, welcome to visit us!

  • CPHI & PMEC China 2024 Ended Successfully

    From June 19 to 21, the 22nd World Pharmaceutical Raw Materials China Exhibition (CPHI China 2024), organized by Informa Markets and China Chamber of Commerce for Import and Export of Pharmaceutical and Health Products and co-organized by Shanghai Bohua International Exhibition Co., LTD., was held in Shanghai. Nearly 3,500 well-known exhibitors at home and abroad gathered in Shanghai New International Expo Center (Pudong), attracting more than 60,000 professional buyers from more than 150 countries and regions, and a total of more than 90,000 industry colleagues to participate in the event.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept